Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article is for informational purposes only. It is not medical advice, diagnosis, or treatment. Not medical advice. If you have cardiovascular disease, hypertension, or any condition requiring medical management, consult a qualified healthcare professional before adopting new practices or changing existing treatment.

TL;DR

• Zazen (座禅) is formal seated meditation from the Zen Buddhist tradition, practiced in Japanese monasteries for over a millennium and increasingly in lay and secular wellness contexts worldwide.
• The strongest clinical evidence for meditation and cardiovascular markers comes from MBSR (Mindfulness-Based Stress Reduction) research, not zazen studies specifically. Chiesa and Serretti’s 2010 systematic review in Psychological Medicine found that mindfulness practices are associated with reduced cortisol, improved autonomic balance, and consistent — if modest — effects on blood pressure and heart rate variability in healthy adults.
• Zazen-specific research is smaller in scale. Japanese groups have observed that long-term Zen practitioners show lower sympathetic nervous system activity at rest compared to matched non-meditating samples, but confounding from the full monastic lifestyle (diet, physical activity, low-stress environment) is substantial.
• The American Heart Association’s 2017 Scientific Statement on meditation reviewed the full evidence base across meditation styles and characterized most mindfulness-based approaches as Class IIB evidence for blood pressure reduction — promising but not yet at the standard of a well-powered long-term cardiovascular outcomes trial.
• The most mechanistically coherent explanation for whatever cardiovascular associations exist: regular zazen may support autonomic nervous system balance — specifically, increased parasympathetic and reduced sympathetic activity — which is correlated with improved heart rate variability and lower resting blood pressure in population-level epidemiology. Whether this translates into outcome-level benefit for a person starting the practice at midlife remains unquantified.

What zazen actually is

Zazen translates directly as “seated Zen.” In the Rinzai and Soto schools of Japanese Zen Buddhism — the two main lineages that shaped practice in Japan — zazen is the core formal discipline: sitting upright in a specific posture (full or half lotus, or seiza on a meditation cushion), eyes lowered, breathing focused in the lower abdomen (hara), attention directed toward stillness or, in the Rinzai tradition, toward a koan.

In monastery settings, zazen is practiced in the zendo (meditation hall) in periods of 20–40 minutes, often several times daily. Intensive retreat periods called sesshin last five to seven days, with practitioners sitting eight or more hours each day. Lay practitioners outside Japan more commonly sit one to two 30-minute periods per day.

The physiological conditions zazen produces are measurable. Kasamatsu and Hirai’s 1966 EEG study at Eiheiji and Sojiji temples — published in Folia Psychiatrica et Neurologica Japonica — was the foundational empirical work showing that experienced Zen monks in zazen produced sustained alpha wave activity consistent with relaxed, non-drowsy alertness, with theta wave emergence in the most experienced practitioners. This state was measurably distinct from both ordinary rest and sleep. The basic EEG finding has been replicated in multiple subsequent studies.

What zazen is not: it is not identical to MBSR. Jon Kabat-Zinn’s Mindfulness-Based Stress Reduction program, developed at the University of Massachusetts in 1979, drew partly on vipassana (insight meditation) and some Zen elements, but is an 8-week structured secular clinical program with standardized session protocols and homework. The substantial evidence base built around MBSR does not automatically transfer to zazen, despite the surface resemblance in posture and breath focus. This distinction matters when evaluating the clinical literature.

The MBSR evidence for cardiovascular outcomes

The systematic review most commonly cited in this area is the 2010 paper by Chiesa and Serretti, published in Psychological Medicine, covering the neurobiological and clinical features of mindfulness meditation across available controlled studies. Among the cardiovascular and autonomic findings:

• Studies consistently found mindfulness practice associated with decreased sympathetic nervous system activity markers — reduced cortisol, lower resting heart rate, and improved heart rate variability — compared to waitlist and passive control conditions.
• Blood pressure reductions were directionally consistent but modest in magnitude: typically 3–5 mmHg systolic in participants who were normotensive or prehypertensive at baseline.
• The effect on cortisol — salivary cortisol measured before and after meditation sessions — was among the more robust findings, consistent with a stress-reduction mechanism rather than a direct cardiovascular effect.
• The authors noted substantial heterogeneity in study design: most included trials were small (30–80 participants), follow-up periods rarely extended beyond 8 weeks, and active controls — conditions that matched MBSR’s time and social contact — were uncommon. Without active controls, general effects of group attendance and expectation cannot be excluded.

A 2015 meta-analysis by Gotink and colleagues in PLOS ONE reviewed 23 MBSR studies and found statistically significant improvements across anxiety, depression, and stress measures, with consistent but modest cardiovascular marker shifts. The directional pattern was stable; the effect sizes were not large enough to project substantial clinical impact without longer-term trial data.

The most directly cardiac study to date: Hughes and colleagues conducted a randomized controlled trial (n=93) of MBSR versus an active control in patients with coronary artery disease, published in Psychosomatic Medicine in 2013. The MBSR group showed lower perceived stress and marginally better heart rate variability, but no significant difference in hard cardiovascular endpoints over the trial period.

The 2017 AHA Scientific Statement (“Meditation and Cardiovascular Risk Reduction,” Levine GN et al., Journal of the American Heart Association) synthesized the evidence across multiple meditation styles. Transcendental Meditation received the most favorable classification based on a larger body of longer-duration trials with blood pressure as a primary endpoint. MBSR was rated Class IIB — where usefulness is “less well established by evidence/opinion” — reflecting the genuine state of the evidence: directionally consistent across trials, but not yet confirmed by the kind of long-term, well-powered outcome trials that anchor cardiovascular treatment guidelines.

Class IIB is not a dismissal. It accurately describes a literature that is promising, mechanistically plausible, and not yet scaled to confirm or refute clinical impact.

What zazen-specific research has found

The zazen-specific literature is smaller and more observational than the MBSR trial base.

Kasamatsu and Hirai (1966) established that the physiological state of experienced Zen meditators during zazen is not equivalent to relaxation or drowsiness — it has a distinct autonomic signature. This foundational observation motivated subsequent Japanese research into whether that physiological state, sustained over years of regular practice, might produce measurable differences in cardiovascular health markers.

Autonomic comparisons in long-term practitioners: Research groups at Japanese institutions including Nippon Medical School and Kyushu University, across studies published in the 1990s and 2000s, measured heart rate variability, skin conductance, and respiratory patterns in experienced Zen practitioners versus matched non-meditating controls. The consistent finding: experienced practitioners showed an elevated parasympathetic-to-sympathetic ratio at rest — the autonomic signature independently associated with lower cardiovascular risk in population-level epidemiology.

The confounding risk here is real and worth stating directly. Zen monks who meditate daily also eat structured temple cuisine (typically plant-forward, low in processed food, low in sodium by standard), engage in regular physical labor (cleaning, gardening, cooking), and inhabit low-chronic-stress social environments shaped by a community with shared obligations. Attributing the autonomic profile specifically to zazen — rather than to the full lifestyle cluster — is not warranted from comparative studies alone.

Japanese centenarian habit surveys: Several structured surveys of Japanese centenarians have recorded some form of meditation or spiritual practice as a reported daily habit. Temple communities with strong Zen affiliation have historically shown low rates of cardiovascular mortality in local administrative records. These observations are consistent with the directional hypothesis and broadly align with what the MBSR trial literature shows. They do not isolate zazen as the causal factor.

What this adds up to: regular zazen practice is associated with physiological states — elevated parasympathetic activity, slowed and deepened breathing, increased alpha EEG — that are independently correlated with lower cardiovascular risk in population-level research. The causal chain from regular practice to meaningful cardiovascular outcome reduction in a person starting in midlife has not been established in any controlled trial.

What a practical starting point looks like

Zazen does not require temple affiliation or a formal teacher to begin, though both add depth to long-term practice. The material starting point for most lay practitioners:

A zafu (round meditation cushion) with a zabuton (floor mat) provides the structural support that makes 20–30-minute sitting feasible without lower back strain. The hip elevation from the zafu tilts the pelvis forward slightly, making an upright spine sustainable for longer than it is on a flat surface. Zazen cushion sets cover both components; buckwheat hulls are the traditional fill for zafu and adjust to body shape over time.

For instruction: the two most accessible entry points in English are breath counting (counting exhalations from 1 to 10, returning to 1 when distracted) and shikantaza (“just sitting” — Soto school), which involves open, objectless awareness without a specific anchor. English-language zazen practice books from teachers in both the Rinzai and Soto traditions are widely available and cover both approaches without requiring temple access.

Consistency matters more than session length at the beginning: 20 minutes once or twice daily at a fixed time tends to produce more durable practice than longer irregular sessions.

The same autonomic pathway that zazen is associated with — parasympathetic upregulation, reduced HPA axis activation — appears in other Japanese wellness practices covered in this series. The onsen cardiovascular effects evidence examines the thermal bathing literature, which proposes a related parasympathetic mechanism. The shinrin-yoku (forest bathing) evidence shows consistent cortisol reduction from forest immersion via a different sensory pathway. None of these practices have been tested head-to-head; the cardiovascular research literature treats them as independent interventions.

For the dietary practice that emerged from overlapping cultural contexts — Okinawan and Zen monastic — the hara hachi bu caloric restriction evidence article covers that research using the same calibration framework applied here.

When to check with a doctor first

Zazen is not contraindicated for most healthy adults. Several situations warrant a conversation with a healthcare provider before beginning:

Existing psychiatric conditions — particularly those with dissociative features, psychosis history, or severe trauma. Case reports in the clinical literature describe derealization and psychological distress in vulnerable individuals following intensive meditation practice. Standard beginner practice (20–30 minutes daily) carries substantially lower risk than intensive sesshin retreats, but the flag is relevant for specific populations.

Severe musculoskeletal conditions that make upright floor sitting impossible. Chair modification of zazen posture — sitting upright in a chair without back support, feet flat on the floor — is practiced widely and appears physiologically equivalent for the purposes of most cardiovascular and autonomic outcomes studied.

Cardiovascular or hypertension medication: meditation practice may complement existing treatment; it is not a substitute for medical management. Any changes to a medication protocol require physician oversight.

For most healthy adults, the relevant conversation with a healthcare provider is brief and is more about ruling out edge cases than clearing a standard health barrier. The practice itself carries no meaningful downside risk at beginner levels.

---

Sources: Kasamatsu A, Hirai T. “An electroencephalographic study on the Zen meditation (Zazen).” Folia Psychiatr Neurol Jpn. 1966;20(4):315–336. Chiesa A, Serretti A. “A systematic review of neurobiological and clinical features of mindfulness meditations.” Psychol Med. 2010;40(8):1239–1252. Gotink RA, et al. “Standardised mindfulness-based interventions in healthcare: an overview of systematic reviews and meta-analyses of RCTs.” PLOS ONE. 2015;10(4):e0124344. Hughes JW, et al. “Randomized controlled trial of mindfulness-based stress reduction for prehypertension.” Psychosom Med. 2013;75(8):721–728. Levine GN, et al. “Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association.” J Am Heart Assoc. 2017;6:e002218.